(Q30887409)

27 June 2017

1 reference

title

Bromocriptine versus levodopa in early Parkinson's disease. (English)

1 reference

27 June 2017

0 references

1 reference

C Ramaker

1

1 reference

27 June 2017

J J van Hilten

series ordinal

2

1 reference

27 June 2017

publication date

1 January 2000

1 reference

Cochrane Database of Systematic Reviews

27 June 2017

published in

1 reference

27 June 2017

issue

3

1 reference

27 June 2017

page(s)

CD002258

1 reference

Effect of ergot drugs on central catecholamine neurons: evidence for a stimulation of central dopamine neurons

27 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002258

Identifying relevant studies for systematic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002258

Parkinsonism: onset, progression, and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002258

The role of dopamine agonists in early Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002258

Treatment of Parkinsonism With Levodopa

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002258

Prevalence of Parkinson's disease in the elderly: The Rotterdam Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002258

Early combination therapy (bromocriptine and levodopa) does not prevent motor fluctuations in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002258

10.1002/14651858.CD002258

21 January 2018

Identifiers

DOI

1 reference

27 June 2017

1 reference